Stockscreener 앱 받기
0.9179
1.57%
-0.0146
Abvc Biopharma Inc (ABVC) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Operating Expenses
|
50.43%
0.7795
|
1.5725 | 2.1989 | 1.9644 | 2.295 |
| Operating Income/Loss |
50.43%
-0.7795
|
-1.5725 | -2.9949 | -1.9644 | -2.295 |
| Nonoperating Income/Loss |
73.65%
-0.031
|
-0.1175 | -0.8176 | -0.1186 | -0.0142 |
| Income/Loss From Equity Method Investments |
21.17%
-0.0248
|
-0.0314 | -0.653 | -0.0542 | -0.0449 |
| Income/Loss From Continuing Operations Before Tax |
52.04%
-0.8105
|
-1.6899 | -3.8124 | -2.0829 | -2.3092 |
| Net Income/Loss |
52.04%
-0.8105
|
-1.6899 | -3.8124 | -2.0835 | -2.3328 |
| Attributable To Noncontrolling Interest |
43.29%
-0.0735
|
-0.1297 | -0.2495 | -0.041 | -0.0758 |
| Basic Average Shares |
2.40%
26.06
|
25.45 | 1.5415 | 23.26 | 17.39 |
| Diluted Average Shares |
2.40%
26.06
|
25.45 | 1.5415 | 23.26 | 17.39 |
| Basic Earnings Per Share |
50.00%
-0.03
|
-0.06 | -0.16 | -0.09 | -0.13 |
| Diluted Earnings Per Share |
50.00%
-0.03
|
-0.06 | -0.16 | -0.09 | -0.13 |
4.22%
자본화:
|
볼륨(24시간):